SAVIMS

Vaccine safety & adverse events

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Analysis of Adverse Reactions from Pfizer/BioNTech COVID-19 Vaccine in the UK

Reference: Medicines and Healthcare products Regulatory Agency. (2022). COVID-19 Vaccine Pfizer/BioNTech vaccine analysis. Retrieved from [URL] Summary: The report analyses spontaneous adverse drug reactions (ADRs) reported for the Pfizer/BioNTech COVID-19 vaccine in the UK up to November 23, 2022. It clarifies that reports of suspected ADRs do not confirm causation, as other underlying health issues […]

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Analysis of Excess Mortality in Switzerland (Beck – 2022)(German)

Reference: Beck, K. (2022). Übersterblichkeiten in der Schweiz 2020 bis 2022 (Woche 42). Bericht für MLaw Philipp Kruse, Zürich. Summary: The report examines excess mortality in Switzerland from 2020 to week 42 of 2022, addressing the implications for pandemic measures. It concludes that while there were spikes in mortality, particularly among seniors, the overall figures

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Autopsy Findings of Myocarditis Post Anti-SARS-CoV-2 Vaccination

Reference: Schwab, C., Domke, L. M., Hartmann, L., Stenzinger, A., Longerich, T., & Schirmacher, P. (2022). Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2 vaccination. Clinical Research in Cardiology, 111(1), 1-12. https://doi.org/10.1007/s00392-022-02129-5 Summary: This study examines the autopsy findings of five individuals who died unexpectedly within 20 days of receiving anti-SARS-CoV-2 vaccinations, analysing the histopathological features

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Neurological Complications Following COVID-19 Vaccination

Reference: Chatterjee, A., & Chakravarty, A. (2022). Neurological complications following COVID‑19 vaccination. Current Neurology and Neuroscience Reports, 22(1), 1-14. https://doi.org/10.1007/s11910-022-01247-x Summary: This article reviews neurological complications associated with COVID-19 vaccination, which may contribute to vaccine hesitancy. Adverse events such as cortical sinus venous thrombosis, Guillain–Barré syndrome, and transverse myelitis are considered serious, though their overall

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Treatment, Vaccine safety & adverse events, Vaccines, Viral illnesses

FDA Oversight of Clinical Trials Criticised

Reference: Demasi, M. (2022). FDA oversight of clinical trials is “grossly inadequate,” say experts. BMJ, 379, o2628. http://doi.org/10.1136/bmj.o2628 Summary: Experts are raising alarms about the US Food and Drug Administration’s (FDA) oversight of clinical trials, particularly following the expedited development of Covid-19 vaccines. A complaint by Brook Jackson, a former employee at Ventavia Research Group,

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Current Knowledge on mRNA Vaccine Excretion and Potential Risks

Reference: Banoun, H. (2022). Current state of knowledge on the excretion of mRNA and spike produced by anti-COVID-19 mRNA vaccines; possibility of contamination of the entourage of those vaccinated by these products. Infectious Diseases Research, 3(4), 22. https://doi.org/10.53388/IDR20221125022 Summary: The article examines the potential for excretion of mRNA and spike protein from COVID-19 mRNA vaccines,

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

SARS-CoV-2 Spike Protein and Hemagglutination: A Study on COVID-19 Morbidities

Reference: Boschi, C., Scheim, D. E., Bancod, A., Millitello, M., Le Bideau, M., Colson, P., Fantini, J., & La Scola, B. (2022). SARS-CoV-2 spike protein induces hemagglutination: Implications for COVID-19 morbidities and therapeutics and for vaccine adverse effects. bioRxiv. https://doi.org/10.1101/2022.11.24.517882 Summary: The study investigates how the SARS-CoV-2 spike protein facilitates hemagglutination (HA) in red blood

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Concerns Over Pfizer’s COVID Vaccine and Immune System Impact

Reference: The Exposé. (2022, November 7). Pfizer’s clinical trial papers prove COVID vaccines destroy the immune system. https://expose-news.com/2022/11/07/pfizer-trial-proves-covid-vaccine-decimates-immune-system Summary: The Exposé article raises alarming concerns regarding Pfizer’s COVID-19 vaccine, citing data from its Phase I-III clinical trials. It reports that the sepsis death rate among double-vaccinated participants was twenty-one times higher than expected, while the

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

VAERS COVID-19 Vaccine Adverse Events Data

Reference: OpenVAERS. (2023). VAERS COVID-19 vaccine adverse events data. Retrieved from https://www.openvaers.com/covid-data Summary: The VAERS COVID-19 Vaccine Adverse Events Data provides a comprehensive overview of reported adverse events following COVID-19 vaccinations in the United States. The data is sourced from the Vaccine Adverse Event Reporting System (VAERS), which is a national system for monitoring the

Scroll to Top